An external quality assessment feasibility study; cross laboratory comparison of haemagglutination inhibition assay and microneutralization assay performance for seasonal influenza serology testing: A FLUCOP study.

Autor: Waldock J; Vaccines, Science Research & Innovation, Medicines and Healthcare Products Regulatory, Potters Bar, United Kingdom., Weiss CD; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, United States., Wang W; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, United States., Levine MZ; Influenza Division, Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Atlanta, GA, United States., Jefferson SN; Influenza Division, Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Atlanta, GA, United States., Ho S; Respiratory Viruses Unit, UK Health Security Agency, Colindale, United Kingdom., Hoschler K; Respiratory Viruses Unit, UK Health Security Agency, Colindale, United Kingdom., Londt BZ; hVivo The Queen Mary Bioenterprises (QMB) Innovation, London, United Kingdom., Masat E; hVivo The Queen Mary Bioenterprises (QMB) Innovation, London, United Kingdom., Carolan L; World Health Organisation (WHO) Collaborating Centre for Reference and Research on Influenza, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia., Sánchez-Ovando S; World Health Organisation (WHO) Collaborating Centre for Reference and Research on Influenza, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.; Department of Infectious Diseases, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia., Fox A; World Health Organisation (WHO) Collaborating Centre for Reference and Research on Influenza, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.; Department of Infectious Diseases, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia., Watanabe S; Center for Influenza and Respiratory Virus Research, National Institute of Infectious Diseases: Musashi-Murayama, Tokyo, Japan., Akimoto M; Center for Influenza and Respiratory Virus Research, National Institute of Infectious Diseases: Musashi-Murayama, Tokyo, Japan., Sato A; Center for Influenza and Respiratory Virus Research, National Institute of Infectious Diseases: Musashi-Murayama, Tokyo, Japan., Kishida N; Center for Influenza and Respiratory Virus Research, National Institute of Infectious Diseases: Musashi-Murayama, Tokyo, Japan., Buys A; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases (NICD) of the National Health Laboratory Services, Johannesburg, South Africa., Maake L; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases (NICD) of the National Health Laboratory Services, Johannesburg, South Africa., Fourie C; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases (NICD) of the National Health Laboratory Services, Johannesburg, South Africa., Caillet C; Department of Research and Development, Sanofi, Lyon, France., Raynaud S; Department of Research and Development, Sanofi, Lyon, France., Webby RJ; Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, TN, United States., DeBeauchamp J; Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, TN, United States., Cox RJ; Influenza Centre, Department of Clinical Sciences, University of Bergen, Bergen, Norway., Lartey SL; Influenza Centre, Department of Clinical Sciences, University of Bergen, Bergen, Norway., Trombetta CM; Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy., Marchi S; Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy., Montomoli E; Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy., Sanz-Muñoz I; National Influenza Centre of Valladolid, Instituto de Estudios de Ciencias de la Salud de Castilla y León (ICSCYL), Edificio Rondilla, Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Eiros JM; National Influenza Centre of Valladolid, Instituto de Estudios de Ciencias de la Salud de Castilla y León (ICSCYL), Edificio Rondilla, Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Sánchez-Martínez J; National Influenza Centre of Valladolid, Instituto de Estudios de Ciencias de la Salud de Castilla y León (ICSCYL), Edificio Rondilla, Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Duijsings D; Viroclinics, Clinical Virology Services, Rotterdam, Netherlands., Engelhardt OG; Vaccines, Science Research & Innovation, Medicines and Healthcare Products Regulatory, Potters Bar, United Kingdom.

Publikováno v: Frontiers in immunology [Front Immunol] 2023 Feb 28; Vol. 14, pp. 1129765. Date of Electronic Publication: 2023 Feb 28 (Print Publication: 2023).

Underdetection of laboratory-confirmed influenza-associated hospital admissions among infants: a multicentre, prospective study.

Autor: Thompson MG; Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: isq8@cdc.gov., Levine MZ; Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, GA, USA., Bino S; Department of Epidemiology and Control of Infectious Diseases, Institute of Public Health, Tirana, Albania., Hunt DR; Abt Associates, Atlanta, GA, USA., Al-Sanouri TM; The Eastern Mediterranean Public Health Network (EMPHNET), Amman, Jordan., Simões EAF; Center for Global Health, Department of Epidemiology, Colorado School of Public Health, Aurora, CO, USA., Porter RM; Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, GA, USA., Biggs HM; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Gresh L; Sustainable Sciences Institute, Managua, Nicaragua., Simaku A; Department of Epidemiology and Control of Infectious Diseases, Institute of Public Health, Tirana, Albania., Khader IA; The Eastern Mediterranean Public Health Network (EMPHNET), Amman, Jordan., Tallo VL; Research Institute for Tropical Medicine, Department of Health, Muntinlupa, Philippines., Meece JK; Marshfield Clinic Research Foundation, Marshfield, WI, USA., McMorrow M; Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, GA, USA., Mercado ES; Research Institute for Tropical Medicine, Department of Health, Muntinlupa, Philippines., Joshi S; Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, GA, USA., DeGroote NP; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Hatibi I; Department of Epidemiology and Control of Infectious Diseases, Institute of Public Health, Tirana, Albania., Sanchez F; Hospital Infantil Manuel de Jesus Rivera, Ministry of Health, Managua, Nicaragua., Lucero MG; Research Institute for Tropical Medicine, Department of Health, Muntinlupa, Philippines., Faouri S; Al Bashir Hospital, Ministry of Health, Amman, Jordan., Jefferson SN; Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, GA, USA., Maliqari N; General Pediatrics Unit, University Hospital Center 'Mother Teresa', Tirana, Albania., Balmaseda A; Laboratorio Nacional de Virologia, Centro Nacional de Diagnostico y Referencia, Ministry of Health, Managua, Nicaragua., Sanvictores D; Research Institute for Tropical Medicine, Department of Health, Muntinlupa, Philippines., Holiday C; Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, GA, USA., Sciuto C; Abt Associates, Atlanta, GA, USA., Owens Z; Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, GA, USA., Azziz-Baumgartner E; Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, GA, USA., Gordon A; Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA.

Publikováno v: The Lancet. Child & adolescent health [Lancet Child Adolesc Health] 2019 Nov; Vol. 3 (11), pp. 781-794. Date of Electronic Publication: 2019 Sep 03.

Vaccination with 2014-15 Seasonal Inactivated Influenza Vaccine Elicits Cross-Reactive Anti-HA Antibodies with Strong ADCC Against Antigenically Drifted Circulating H3N2 Virus in Humans.

Autor: Zhong W; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention , Atlanta, Georgia ., Gross FL; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention , Atlanta, Georgia ., Holiday C; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention , Atlanta, Georgia ., Jefferson SN; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention , Atlanta, Georgia ., Bai Y; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention , Atlanta, Georgia ., Liu F; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention , Atlanta, Georgia ., Katz JM; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention , Atlanta, Georgia ., Levine MZ; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention , Atlanta, Georgia .

Publikováno v: Viral immunology [Viral Immunol] 2016 May; Vol. 29 (4), pp. 259-62. Date of Electronic Publication: 2016 Mar 07.